Long-term prothionamide compliance: a study carried out in India using a combined formulation containing prothionamide, dapsone and isoniazid.
作者信息
Ellard G A, Kiran K U, Stanley J N
出版信息
Lepr Rev. 1988 Jun;59(2):163-75. doi: 10.5935/0305-7518.19880021.
PMID:3246926
Abstract
摘要
相似文献
1
Long-term prothionamide compliance: a study carried out in India using a combined formulation containing prothionamide, dapsone and isoniazid.长期丙硫异烟胺依从性：在印度开展的一项使用含丙硫异烟胺、氨苯砜和异烟肼复方制剂的研究。
Lepr Rev. 1988 Jun;59(2):163-75. doi: 10.5935/0305-7518.19880021.
2
The Malta experience. Isoprodian-rifampicin combination treatment for leprosy.
Lepr Rev. 1986;57 Suppl 3:29-37. doi: 10.5935/0305-7518.19860090.
3
The impact of MDT implementation in the Tanzania National TB-Leprosy Programme.
Lepr Rev. 1986;57 Suppl 3:63-6. doi: 10.5935/0305-7518.19860096.
4
First assessment of the Malta Leprosy Eradication Project.
Lepr Rev. 1986;57 Suppl 3:42-6. doi: 10.5935/0305-7518.19860092.
5
Prothionamide and dapsone therapy in leprosy--a clinical study.丙硫异烟胺和氨苯砜治疗麻风病的临床研究
Indian J Lepr. 1985 Jan-Mar;57(1):90-6.
6
Ethionamide, prothionamide and thiacetazone self-administration. Studies of patient compliance using isoniazid-marked formulations.乙硫异烟胺、丙硫异烟胺和氨硫脲的自我给药。使用异烟肼标记制剂对患者依从性的研究。
Lepr Rev. 1986 Mar;57(1):9-18. doi: 10.5935/0305-7518.19860003.
7
Does isoniazid increase the hepatotoxicity of the combination prothionamide-dapsone? Isoprodian Study Group.异烟肼会增加丙硫异烟胺-氨苯砜联合用药的肝毒性吗？异普罗地安研究组。
Int J Lepr Other Mycobact Dis. 1992 Dec;60(4):536-41.
8
Combined chemotherapy of multibacillary leprosy patients.
Nihon Rai Gakkai Zasshi. 1986 Jul-Sep;55(3):65-71. doi: 10.5025/hansen1977.55.65.
9
Failure of a prothionamide-containing oral antituberculosis regimen.
S Afr Med J. 1985 Dec 7;68(12):881.
10
Combinations of rifampicin and isoprodian in the treatment of Mycobacterium leprae infections in mice.
Nihon Rai Gakkai Zasshi. 1978 Jan-Mar;47(1):43-7. doi: 10.5025/hansen1977.47.43.
Zotero 插件